Literature DB >> 14646174

Effects of sesamin on aortic oxidative stress and endothelial dysfunction in deoxycorticosterone acetate-salt hypertensive rats.

Daisuke Nakano1, Chie Itoh, Fumie Ishii, Hideaki Kawanishi, Masanori Takaoka, Yoshinobu Kiso, Nobuo Tsuruoka, Takaharu Tanaka, Yasuo Matsumura.   

Abstract

In the present study, we evaluated the relationship between the antihypertensive effect of sesamin, a lignan from sesame oil, and its antioxidative activity in deoxycorticosterone acetate (DOCA)-salt hypertensive rats. After a 5-week treatment period, systolic blood pressure was significantly elevated in normal diet-fed DOCA-salt animals compared with cases in sham-operated animals. Sesamin feeding, tempol (a superoxide dismutase mimetic) treatment or antihypertensive drugs combination (triple therapy; reserpine, hydralazine, hydrochlorothiazide) significantly suppressed the development of DOCA-salt-induced hypertension. Compared with sham-operated rats, the normal diet-fed DOCA-salt rats revealed marked increases in aortic superoxide (O(2)(-)) production. These increases in O(2)(-) production were significantly suppressed by sesamin feeding or tempol treatment, but not by triple therapy. Acetylcholine (Ach)-induced endothelium-dependent relaxation was markedly decreased in normal diet-fed DOCA-salt rats, compared with cases in sham-operated rats. Sesamin feeding and triple therapy significantly improved the DOCA-salt-induced impairment of endothelium-dependent relaxation. However, tempol treatment had no effect on the impaired vasodilator responses induced by DOCA-salt treatment. In DOCA-salt rats with or without sesamin feeding, systolic blood pressure significantly correlated with both aortic O(2)(-) production and endothelium-dependent vascular relaxation. These findings suggest that sesamin feeding inhibits the enhancement of aortic O(2)(-) production in DOCA-salt hypertensive rats, and this effect may contribute to the antihypertensive effect of sesamin. Sesamin feeding-induced improvement of endothelial dysfunction seems to result from the above antioxidative and antihypertensive effects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14646174     DOI: 10.1248/bpb.26.1701

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  18 in total

1.  Reversal of cardiac dysfunction by selective ET-A receptor antagonism.

Authors:  Anthony Allan; Andrew Fenning; Scott Levick; Andrew Hoey; Lindsay Brown
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

Review 2.  Conversion of extracellular ATP into adenosine: a master switch in renal health and disease.

Authors:  Karen M Dwyer; Bellamkonda K Kishore; Simon C Robson
Journal:  Nat Rev Nephrol       Date:  2020-07-08       Impact factor: 28.314

3.  Effects of sesame seed supplementation on lipid profile and oxidative stress biomarkers in patients with knee osteoarthritis.

Authors:  Mahdieh Khadem Haghighian; Beitollah Alipoor; Bina Eftekhar Sadat; Aida Malek Mahdavi; Abdolvahab Moghaddam; Amir-Mansour Vatankhah
Journal:  Health Promot Perspect       Date:  2014-07-12

4.  Sesame oil consumption exerts a beneficial effect on endothelial function in hypertensive men.

Authors:  Kalliopi Karatzi; Kimon Stamatelopoulos; Maritta Lykka; Pigi Mantzouratou; Sofia Skalidi; Nikolaos Zakopoulos; Christos Papamichael; Labros S Sidossis
Journal:  Eur J Prev Cardiol       Date:  2012-01-25       Impact factor: 7.804

5.  Aldosterone does not contribute to renal p21 expression during the development of angiotensin II-induced hypertension in mice.

Authors:  Daisuke Nakano; Bai Lei; Kento Kitada; Hirofumi Hitomi; Hiroyuki Kobori; Hirohito Mori; Kazushi Deguchi; Tsutomu Masaki; Tohru Minamino; Akira Nishiyama
Journal:  Am J Hypertens       Date:  2011-11-24       Impact factor: 2.689

6.  Formation of two methylenedioxy bridges by a Sesamum CYP81Q protein yielding a furofuran lignan, (+)-sesamin.

Authors:  Eiichiro Ono; Masaaki Nakai; Yuko Fukui; Namino Tomimori; Masako Fukuchi-Mizutani; Masayuki Saito; Honoo Satake; Takaharu Tanaka; Masumi Katsuta; Toshiaki Umezawa; Yoshikazu Tanaka
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-19       Impact factor: 11.205

7.  Sesamin ameliorates arterial dysfunction in spontaneously hypertensive rats via downregulation of NADPH oxidase subunits and upregulation of eNOS expression.

Authors:  Jun-xiu Zhang; Jie-ren Yang; Guo-xiang Chen; Li-juan Tang; Wen-xing Li; Hui Yang; Xiang Kong
Journal:  Acta Pharmacol Sin       Date:  2013-04-29       Impact factor: 6.150

8.  Combined effect of sesamin and α-lipoic acid on hepatic fatty acid metabolism in rats.

Authors:  Takashi Ide; Ayana Azechi; Sayaka Kitade; Yoko Kunimatsu; Natsuko Suzuki; Chihiro Nakajima
Journal:  Eur J Nutr       Date:  2012-06-30       Impact factor: 5.614

9.  Sesamin protects against renal ischemia reperfusion injury by promoting CD39-adenosine-A2AR signal pathway in mice.

Authors:  Ke Li; Xia Gong; Ge Kuang; Rong Jiang; Jingyuan Wan; Bin Wang
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

Review 10.  Chemistry and antihypertensive effects of tempol and other nitroxides.

Authors:  Christopher S Wilcox; Adam Pearlman
Journal:  Pharmacol Rev       Date:  2008-12       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.